XML 48 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Fair Value of Derivative Instruments
Derivative instruments were recorded at fair value in the condensed consolidated balance sheets as follows:
 As of March 31, 2025As of December 31, 2024
Asset
Derivatives
Liability
Derivatives
Asset
Derivatives
Liability
Derivatives
 (in millions)
Derivatives designated as
accounting hedges:
Interest rate contracts (1)
$63 $60 $84 $35 
Net investment hedge derivative contracts (2)
244 201 305 50 
$307 $261 $389 $85 
Derivatives not designated as
   accounting hedges:
Currency exchange contracts$176 $146 $302 $118 
Commodity contracts911 752 2,205 1,522 
Interest rate contracts— — 
$1,090 $898 $2,510 $1,640 
Total fair value$1,397 $1,159 $2,899 $1,725 

(1)Interest rate contracts designated as cash flow hedging instruments.
(2)Net investment hedge derivative contracts consist of cross-currency interest rate swaps, forward contracts and options. We also designate some of our non-U.S. dollar denominated debt to hedge a portion of our net investments in our non-U.S. operations. This debt is not reflected in the table above, but is included in long-term debt discussed in Note 7, Debt and Borrowing Arrangements. Both net investment hedge derivative contracts and non-U.S. dollar denominated debt acting as net investment hedges are also disclosed in the Derivative Volume table and the Hedges of Net Investments in International Operations section appearing later in this footnote.
Fair Value of Offsetting Assets
We recorded the fair value of our derivative instruments in the condensed consolidated balance sheets as follows:

 As of March 31, 2025As of December 31, 2024
 (in millions)
Other current assets
$1,164 $2,545 
Other assets
233 354 
Other current liabilities
1,000 1,641 
Other liabilities
159 84 
Fair Value of Offsetting Liabilities
We recorded the fair value of our derivative instruments in the condensed consolidated balance sheets as follows:

 As of March 31, 2025As of December 31, 2024
 (in millions)
Other current assets
$1,164 $2,545 
Other assets
233 354 
Other current liabilities
1,000 1,641 
Other liabilities
159 84 
Summary of Derivative Instrument Fair Value Measurement Inputs
The fair values (asset/(liability)) of our derivative instruments were determined using:
 As of March 31, 2025
 Total
Fair Value of Net
Asset/(Liability)
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
Significant
Other Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
 (in millions)
Currency exchange contracts$30 $— $30 $— 
Commodity contracts159 106 53 — 
Interest rate contracts— — 
Net investment hedge contracts43 — 43 — 
Total derivatives$238 $106 $132 $— 
 As of December 31, 2024
 Total
Fair Value of Net
Asset/(Liability)
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
Significant
Other Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
 (in millions)
Currency exchange contracts$184 $— $184 $— 
Commodity contracts683 (111)794 — 
Interest rate contracts52 — 52 — 
Net investment hedge contracts255 — 255 — 
Total derivatives$1,174 $(111)$1,285 $— 
Schedule of Notional Values of Derivative Instruments
The gross notional values of our hedging instruments were:
 Notional Amount
 As of March 31,
2025
As of December 31, 2024
 (in millions)
Currency exchange contracts
$16,284 $13,538 
Commodity contracts
17,142 16,210 
Interest rate contracts4,536 5,336 
Net investment hedges:
Net investment hedge derivative contracts9,421 8,647 
Non-U.S. dollar debt designated as net investment hedges:
Euro notes
3,446 3,298 
Swiss franc notes
226 220 
Canadian dollar notes
452 869 
Schedule of Net Investment Hedges
Net investment hedge derivative contract impacts on other comprehensive earnings and net earnings were:
 For the Three Months Ended
March 31,
 20252024
 (in millions)
(Loss)/gain on NIH contracts (1)
$(201)$220 
Amounts excluded from the assessment of hedge effectiveness (2)
57 41 

(1)Amounts recorded for unsettled and settled NIH derivative contracts are recorded within the cumulative translation adjustment section of other comprehensive earnings/(losses).
(2)We assess the effectiveness of NIH relationships based on spot rates and amortize the initial value attributable to the excluded component to earnings over the life of the hedging instrument within interest and other expense, net.
ains/(losses) related to non-U.S. dollar debt designated as hedges of net investments in international operations, which are recorded within the cumulative translation adjustment section of other comprehensive earnings/(losses), were:
 For the Three Months Ended
March 31,
 20252024
 (in millions)
Euro notes$(147)$79 
Swiss franc notes(6)26 
Canadian notes— 10 
Summary of Economic Hedges Pre-tax gains/(losses) recorded in net earnings for economic hedges were:
 For the Three Months Ended
March 31,
 20252024
 (in millions)
Currency exchange contracts:
Cost of sales
$(131)$25 
Selling, general and administrative expenses
— 
Interest and other expense, net
90 56 
Commodity contracts - Cost of sales
(409)1,184 
Total$(450)$1,272 
Schedule of Contingent Consideration
The following is a summary of our contingent consideration liability activity:

 For the Three Months Ended
March 31,
 20252024
 (in millions)
Liability at beginning of period$179 $680 
Changes in fair value
(12)23 
Liability at end of period$167 $703 

Contingent consideration was recorded at fair value in the condensed consolidated balance sheets as follows:

 As of March 31, 2025
 Total Fair Value of
Liability
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
Significant
Other Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
 (in millions)
Clif Bar (1)
$99 $— $— $99 
Other (2)
68 — — 68 
Total contingent consideration$167 $— $— $167 

 As of December 31, 2024
 Total Fair Value of
Liability
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
Significant
Other Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
 (in millions)
Clif Bar (1)
$124 $— $— $124 
Other (2)
55 — — 55 
Total contingent consideration$179 $— $— $179 

(1)In connection with the Clif Bar acquisition, we entered into a contingent consideration arrangement that may require us to pay additional consideration to the sellers for achieving certain net revenue, gross profit and EBITDA targets in 2025 and 2026 that exceed our base financial projections for the business implied in the upfront purchase price. The possible payments range from zero to a maximum total of $2.4 billion, with higher payouts requiring the achievement of targets that generate rates of returns in excess of the base financial projections. The contingent consideration liabilities are recorded at fair value and primarily recorded in other liabilities as of March 31, 2025 and December 31, 2024. The estimated fair value of the contingent consideration obligation is determined using a Monte Carlo simulation. Significant assumptions used in assessing the fair value of the liability include financial projections for net revenue, gross profit and EBITDA, as well as discount and volatility rates. Fair value adjustments are primarily recorded in selling, general and administrative expenses in the condensed consolidated statement of earnings.
(2)The other contingent consideration liabilities are recorded at fair value and recorded in other liabilities as of March 31, 2025 and December 31, 2024. Fair value adjustments were recorded in selling, general and administrative expenses in the condensed consolidated statement of earnings.